| Title: |
The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study. |
| Authors: |
Carra, Fábio Alfano, de Melo, Maria Edna, Stumpf, Matheo A. M., Cercato, Cintia, Fernandes, Ariana E., Mancini, Marcio C., EPICCoV Study Group, Hirota, Adriana, Kanasiro, Alberto Kendy, Crescenzi, Alessandra, Fernandes, Amanda Coelho, Miethke-Morais, Anna, Bellintani, Arthur Petrillo, Canasiro, Artur Ribeiro, Carneiro, Bárbara Vieira, Zanbon, Beatriz Keiko, Pinheiro, Bernardo, Batista, Senna Nogueira, Nicolao, Bianca Ruiz, Besen, Bruno Adler Maccagnan Pinheiro |
| Source: |
Diabetology & Metabolic Syndrome; 1/19/2024, Vol. 16 Issue 1, p1-7, 7p |
| Subject Terms: |
COVID-19, HOSPITAL patients, RENAL replacement therapy, COHORT analysis, ARTIFICIAL respiration, HOSPITAL admission & discharge |
| Abstract: |
Background: Obesity is believed to be a risk factor for COVID-19 and unfavorable outcomes, although data on this remains to be better elucidated. Objective: To evaluate the impact of obesity on the endpoints of patients hospitalized due to SARS-CoV-2. Methods: This retrospective cohort study evaluated patients hospitalized at a tertiary hospital (Hospital das Clínicas da Faculdade de Medicina da USP) from March to December 2020. Only patients positive for COVID-19 (real-time PCR or serology) were included. Data were collected from medical records and included clinical and demographic information, weight and height, SAPS-3 score, comorbidities, and patient-centered outcomes (mortality, and need for mechanical ventilation, renal replacement therapy, or vasoactive drugs). Patients were divided into categories according to their BMI (underweight, eutrophic, overweight and obesity) for comparison porpoise. Results: A total of 2547 patients were included. The mean age was 60.3 years, 56.2% were men, 65.2% were white and the mean BMI was 28.1 kg/m2. SAPS-3 score was a risk factor for all patient-centered outcomes (HR 1.032 for mortality, OR 1.03 for dialysis, OR 1.07 for vasoactive drug use, and OR 1.08 for intubation, p < 0.05). Male sex increased the risk of death (HR 1.175, p = 0.027) and dialysis (OR 1.64, p < 0.001), and underweight was protective for vasoactive drug use (OR 0.45, p = 0.027) and intubation (OR 0.31, p < 0.003). Conclusion: Obesity itself was not an independent factor for worse patient-centered outcomes. Critical clinical state (indirectly evaluated by SAPS-3) appears to be the most important variable related to hard outcomes in patients infected with COVID-19. Highlights: Obesity is present in up to 30% of patients hospitalized with COVID-19 Obesity itself is not related to key endpoints such as mortality and need for dialysis, orotracheal intubation, or vasoactive drug SAPS-3 is the best predictor for worse outcomes in SARS-CoV-2 infection [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetology & Metabolic Syndrome is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
